CORONAVIRUS/Taiwan rules out regular use of antiparasitic drug to treat COVID
Taipei, June 14 (CNA) As the common antiparasitic ivermectin is being touted as a cure for COVID-19 in many parts of the world, Taiwan's experts on Monday warned against regular use of the drug in COVID-19 treatment, citing a lack of solid evidence.
"Following an expert meeting, we do not recommend regular use of ivermectin in treating COVID-19 due to lack of enough evidence," Chang Shan-chwen (張上淳), convener of the Central Epidemic Command Center's (CECC) expert advisory panel, told a daily press briefing.
According to a recent report in the American Journal of Therapeutics, meta-analyses based on 18 randomized controlled treatment trials of ivermectin in COVID-19 have found large, statistically significant reductions in mortality, time to clinical recovery, and time to viral clearance.
"Furthermore, results from numerous controlled prophylaxis trials report significantly reduced risks of contracting COVID-19 with the regular use of ivermectin," the report said.
Although initial findings showed that ivermectin seemed effective in the prevention and treatment of COVID-19, Chang, however, said no meaningful evidence has been discovered to fully verify that it helps bring down patients' mortality or intubation rate.
Neither is there evidence to prove that it speeds up the elimination of the coronavirus or shortens the length of a patient's hospital stay, because of the limited number of cases studied, he said.
Ivermectin, a medication used to treat many types of parasite infestations, was first used in 1988 to treat river blindness, a disease caused by infection from the parasitic worm Onchocerca volvulus. Since 2012, several studies showed antiviral effects of ivermectin on RNA viruses such as flu, dengue fever and acquired immunodeficiency syndrome (AIDS).
Therefore, demand for approval of the drug is growing across the world, with some countries recommending ivermectin as a cure for COVID-19 patients -- despite leading health authorities consistently warning against its use.
As neither the World Health Organization nor the European Union or the United States have included ivermectin in their guidelines for COVID-19 treatment, the CECC decided not to recommend a regular use of the drug for such a purpose, Chang said.
He warned COVID-19 patients against buying the drug over the counter to treat the disease due to potential side effects caused by inappropriate use.
- Taipei eases COVID-19 restrictions on indoor diningWith the spread of coronavirus slowing, Taipei announced Monday that COVID-19 restrictions on indoor dining at restaurants will be eased, with people no longer having to be ...09/27/2021 10:20 PM
- People eligible for 2nd AstraZeneca jab will need online appointmentPeople who are eligible to receive their second dose of the AstraZeneca COVID-19 vaccine will need to make their appointments online, rather than wait for notification from their ...09/27/2021 10:02 PM
- Taiwan eases COVID-19 restrictions at movie theaters, sports venuesTaiwan will ease some COVID-19 restrictions at movie theaters, sports venues, and train stations this week, and allow the reopening of more entertainment venues on Oct. 5 if the ...09/27/2021 07:44 PM
Entry to CPTPP expected to reduce Taiwan's single market reliance09/28/2021 12:52 AM
Taiwan team to look into Fukushima nuclear plant's wastewater release09/28/2021 12:10 AM
Taiwan to impose anti-dumping tariffs on certain ceramic tile suppliers09/27/2021 11:16 PM
Museum to hold exhibition on 100 years of epidemic prevention in Taiwan09/27/2021 10:57 PM
Taiwan's economy stays in growth mode for 7th straight month in August09/27/2021 10:40 PM